Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Sep;116(1):1644–1648. doi: 10.1111/j.1476-5381.1995.tb16385.x

Effect of trilinolein on cyclic nucleotide formation in human platelets: relationship with its antiplatelet effect and nitric oxide synthesis.

Y C Shen 1, C Y Hong 1
PMCID: PMC1908908  PMID: 8564231

Abstract

1. Trilinolein, a triacylglycerol with linoleic acid as the only fatty acid residue in all three esterified positions of glycerol, was recently reported to have an inhibitory effect on adrenaline-induced platelet aggregation. In the present study, we found that trilinolein at concentrations ranging from 0.01 to 1 microM increased cyclic GMP formation and decreased cyclic AMP formation in washed human platelets. Both NG-nitro-L-arginine methyl ester (L-NAME) and methylene blue attenuated the trilinolein-induced increase in cyclic GMP. 2. Adrenaline decreased not only the production of cyclic AMP but also that of cyclic GMP. Trilinolein antagonized the inhibitory effect of adrenaline on cyclic GMP formation, but potentiated the inhibitory effect of adrenaline on cyclic AMP accumulation. 3. Both trilinolein and adrenaline enhanced intracellular calcium but the increment of intracellular calcium induced by them was much less than that produced by thrombin. 4. We propose that the anti-platelet effect of trilinolein is mediated through an increase in cyclic GMP, and that the change in cyclic GMP results from stimulation of nitric oxide synthesis in platelets. 5. We also propose that reduction of both cyclic AMP and cyclic GMP are involved in adrenaline-induced platelet aggregation.

Full text

PDF
1644

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brandi M. L., Rotella C. M., Tanini A., Toccafondi R. S. Evidence for alpha-adrenergic receptors acting through the guanylate cyclase system in human cultured thyroid cells. Acta Endocrinol (Copenh) 1983 Sep;104(1):64–68. doi: 10.1530/acta.0.1040064. [DOI] [PubMed] [Google Scholar]
  2. Brass L. F., Woolkalis M. J., Manning D. R. Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase. J Biol Chem. 1988 Apr 15;263(11):5348–5355. [PubMed] [Google Scholar]
  3. Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985 Mar 25;260(6):3440–3450. [PubMed] [Google Scholar]
  4. Haslam R. J., Davidson M. M., Desjardins J. V. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem J. 1978 Oct 15;176(1):83–95. doi: 10.1042/bj1760083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hong C. Y., Lai L. J., Shiao M. S., Chiang B. N. Effect of triacylglycerols on erythrocyte deformability in vitro. Prostaglandins Leukot Essent Fatty Acids. 1993 May;48(5):351–353. doi: 10.1016/0952-3278(93)90114-c. [DOI] [PubMed] [Google Scholar]
  6. Hong C. Y., Lai L. J., Yeh S. F. Linoleate-rich triacylglycerol in Panax pseudo-ginseng improves erythrocyte deformability in vitro. Planta Med. 1993 Aug;59(4):323–325. doi: 10.1055/s-2006-959691. [DOI] [PubMed] [Google Scholar]
  7. Jakobs K. H., Böhme E., Mocikat S. Proceedings: Cyclic GMP formation in human platelets. Naunyn Schmiedebergs Arch Pharmacol. 1974;282(Suppl):suppl 282–282:R40. [PubMed] [Google Scholar]
  8. Jaraki O., Strauss W. E., Francis S., Loscalzo J., Stamler J. S. Antiplatelet effects of a novel antianginal agent, nicorandil. J Cardiovasc Pharmacol. 1994 Jan;23(1):24–30. doi: 10.1097/00005344-199401000-00024. [DOI] [PubMed] [Google Scholar]
  9. Karniguian A., Legrand Y. J., Caen J. P. Prostaglandins: specific inhibition of platelet adhesion to collagen and relationship with cAMP level. Prostaglandins. 1982 Apr;23(4):437–457. doi: 10.1016/0090-6980(82)90108-3. [DOI] [PubMed] [Google Scholar]
  10. Lai L. J., Shen Y. C., Hong C. Y. Trilinolein inhibits epinephrine-induced human platelet aggregation. Thromb Res. 1994 Nov 1;76(3):281–287. doi: 10.1016/0049-3848(94)90199-6. [DOI] [PubMed] [Google Scholar]
  11. Mellion B. T., Ignarro L. J., Ohlstein E. H., Pontecorvo E. G., Hyman A. L., Kadowitz P. J. Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 1981 May;57(5):946–955. [PubMed] [Google Scholar]
  12. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  13. Mustard J. F., Perry D. W., Ardlie N. G., Packham M. A. Preparation of suspensions of washed platelets from humans. Br J Haematol. 1972 Feb;22(2):193–204. doi: 10.1111/j.1365-2141.1972.tb08800.x. [DOI] [PubMed] [Google Scholar]
  14. Nathan C., Xie Q. W. Nitric oxide synthases: roles, tolls, and controls. Cell. 1994 Sep 23;78(6):915–918. doi: 10.1016/0092-8674(94)90266-6. [DOI] [PubMed] [Google Scholar]
  15. Perchellet J. P., Sharma R. K. Ectopic alpha-adrenergic mediated accumulation of guanosine 3',5'-monophosphate in isolated adrenocortical carcinoma cells. Endocrinology. 1980 May;106(5):1589–1593. doi: 10.1210/endo-106-5-1589. [DOI] [PubMed] [Google Scholar]
  16. Pollock W. K., Rink T. J. Thrombin and ionomycin can raise platelet cytosolic Ca2+ to micromolar levels by discharge of internal Ca2+ stores: studies using fura-2. Biochem Biophys Res Commun. 1986 Aug 29;139(1):308–314. doi: 10.1016/s0006-291x(86)80114-0. [DOI] [PubMed] [Google Scholar]
  17. Radomski M. W., Palmer R. M., Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5193–5197. doi: 10.1073/pnas.87.13.5193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Radomski M. W., Palmer R. M., Moncada S. Characterization of the L-arginine:nitric oxide pathway in human platelets. Br J Pharmacol. 1990 Oct;101(2):325–328. doi: 10.1111/j.1476-5381.1990.tb12709.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rink T. J., Smith S. W., Tsien R. Y. Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca-independent activation for shape-change and secretion. FEBS Lett. 1982 Nov 1;148(1):21–26. doi: 10.1016/0014-5793(82)81234-9. [DOI] [PubMed] [Google Scholar]
  20. Ruoff H. J. Rat gastric mucosal cAMP and cGMP after adrenergic stimulation and blockade. Eur J Pharmacol. 1977 Aug 15;44(4):349–354. doi: 10.1016/0014-2999(77)90309-0. [DOI] [PubMed] [Google Scholar]
  21. Schwartz J. P. Catecholamine-mediated elevation of cyclic GMP in the rat C-6 glioma cell line. J Cyclic Nucleotide Res. 1976 Jul-Aug;2(4):287–296. [PubMed] [Google Scholar]
  22. Trovati M., Massucco P., Mattiello L., Mularoni E., Cavalot F., Anfossi G. Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect. Diabetes. 1994 Aug;43(8):1015–1019. doi: 10.2337/diab.43.8.1015. [DOI] [PubMed] [Google Scholar]
  23. Tsai S. K., Chan P., Lee T. Y., Yung J. M., Hong C. Y. Trilinolein improves erythrocyte deformability during cardiopulmonary bypass. Br J Clin Pharmacol. 1994 May;37(5):457–459. doi: 10.1111/j.1365-2125.1994.tb05714.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES